News
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Deal with proven culprits for sudden cardiac deaths in Karnataka's Hassan district than the unproven
Twenty-four “sudden” deaths over 40 days in May-June this year in Hassan district, suspected to be due to cardiac issues, have sent shock waves across the state ...
Scientists say the current COVID vaccine is effective against the Nimbus variant and is considered a “variant under ...
Dr Wong Ping-leung gets nine months in prison, as court hears how he made more than HK$4.6 million from those wanting to avoid vaccinations.
Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.
Amid the sultry summer months, a few signs of fall become apparent, such as the appearance of school supplies on stores ...
Explore more
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...
According to WHO, globally, this variant contributed to 23 per cent of global COVID-19 cases as of last month.
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one ...
A Qatar-based study involving 121,700 patients has underscored the importance of the post-vaccination monitoring to optimise ...
A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to know about symptoms and vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results